The cardiovascular risk associated with insulin resistance is largely mediated through atherogenic dyslipidemia and blood pressure
Assessment
Evidence favors the claim, but the chain is incomplete or the sources are secondary.
The best direct test of this claim is causal mediation analysis of surrogate insulin-resistance indices, and it favors the claim. In UK Biobank (403,335 participants), dyslipidemia explained roughly 46% and hypertension 15% of the triglyceride-glucose index's association with incident cardiovascular disease, so the two pathways together account for a majority of the signal, which is what "largely mediated" asserts via substantial attenuation once lipids and blood pressure are accounted for. Both mechanistic legs are well grounded: insulin resistance reliably produces the atherogenic lipid triad and contributes causally to higher blood pressure, the latter the smaller and more confounded contributor.
The main qualification is that the mediated fraction is measure- and population-dependent, and a real direct component remains: insulin-resistance surrogates still predict cardiovascular events after adjustment for conventional risk factors. That residual is compatible with the claim rather than fatal to it, since partial mediation of a majority share still leaves a significant remainder; it bounds how large "largely" can be without negating it. The claim would be strengthened by mediation analyses using HOMA-IR or fasting-insulin measures with full lipoprotein (apoB/remnant) phenotyping, and by Mendelian-randomization designs that partition direct from indirect genetic effects; the triglyceride-glucose index embeds triglycerides by construction and likely overstates the lipid share.
Full reasoning: the evidence and decisions behind this verdict
Status rests on a holistic reading of the mediation and adjustment literature, not any single edge.
Supporting evidence. The strongest direct test is causal mediation analysis. In UK Biobank (403,335 participants; Cardiovascular Diabetology, www.ncbi.nlm.nih.gov/pmc/articles/PMC9936712/), dyslipidemia explained 45.8% and hypertension 15.0% of the triglyceride-glucose index's association with incident CVD (type 2 diabetes a further 27.0%), and the authors state the associations were "largely mediated" by these comorbidities. Lipids plus blood pressure together ≈ 61%, a majority, which is the quantitative content of the claim via substantial attenuation after adjustment for lipids and blood pressure. The two mechanistic legs are well grounded: insulin resistance produces the atherogenic lipid triad is textbook metabolic physiology (near-certain), and it causally raises blood pressure is supported by Mendelian randomization linking genetically predicted insulin resistance to hypertension (www.ncbi.nlm.nih.gov/pmc/articles/PMC10940700/), though a smaller and partly confounded contributor.
Countervailing evidence. Many cohorts find the insulin-resistance signal survives full adjustment, the basis of the residual-risk line. These findings are compatible with the claim: partial mediation of a majority share leaves a significant residual, so "independently associated" does not negate "largely mediated." They do bound how large "largely" can be and show the direct component is real, not zero.
Why supported and not higher or lower. The aggregate favors majority mediation, so not contradicted or merely contested. It is not verified because the mediated fraction is measure- and population-dependent: TyG embeds triglycerides by construction and likely overstates the lipid share relative to HOMA-IR or fasting-insulin measures, and no analysis cleanly isolates the split with full lipoprotein (apoB/remnant) phenotyping. Confidence 0.6 reflects the possibility that "largely" fails under HOMA-IR-based mediation or in populations where the direct component dominates; credence 0.65 is the probability that a majority of the risk is in fact mediated by these two pathways. What would move it: HOMA-IR mediation analyses with complete lipoprotein phenotyping, and MR-mediation designs partitioning direct vs indirect genetic effects.
Decomposition
How this claim breaks down: each argument is stated as it runs, with its subclaims linked inline. ↗︎ opens a subclaim; the map shows how they fit together.
Because insulin resistance produces atherogenic dyslipidemia and contributes to elevated blood pressure, these are causal pathways from insulin resistance to cardiovascular disease; and since the insulin-resistance–cardiovascular association attenuates substantially once lipids and blood pressure are accounted for, most of that risk travels through them.
The inference is structurally sound: if insulin resistance drives cardiovascular risk chiefly through atherogenic dyslipidemia and higher blood pressure, and the association attenuates substantially once those are accounted for, then most of the risk travels through them. The argument lives or dies on the attenuation premise: "substantially" must reach a majority share for "largely" to follow, and the leading estimate comes from a surrogate index that embeds triglycerides and so may overstate the lipid leg. The two mechanistic legs are secure, so the caveat is quantitative, not directional.
Because insulin-resistance surrogates still predict cardiovascular events after adjustment for conventional risk factors, which include lipids and blood pressure, a meaningful share of the risk is not carried by those pathways, weighing against the claim that it is largely mediated by them.
The inference is valid as far as it goes: because insulin-resistance surrogates still predict events after adjustment for conventional risk factors, a non-zero share of the risk is not carried by the lipid and blood-pressure pathways. But it weighs against the claim only weakly, because a real residual is fully compatible with majority mediation: partial mediation of most of the signal still leaves an independent component to detect. The argument therefore bounds how large "largely" can be rather than defeating it, and its force depends on residual associations being large enough to leave the mediated fraction below a majority.
Provenance
Where this claim has been said, linked to its canonical form.
These associations were largely mediated by greater prevalence of dyslipidemia, type 2 diabetes, and hypertension.
Mediation analysis of two surrogate insulin-resistance indices in UK Biobank; dyslipidemia explained 45.8% and hypertension 15.0% of the TyG index's association with CVD.
Assessment history
0 status changes over 2 assessments. full history →
Cite this claim: a formal citation with its evidence attached
Contribute
Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.
The attention this claim received was paid for by a funded mandate. Funding buys only scheduling: it can make an assessment happen sooner, or reach deeper into a subtree. It has no influence on what the assessment concludes, and none on which claims enter the graph; assessments run under the same public standards whoever pays, funders never see or shape a verdict before anyone else, and mandates that attempt to steer conclusions are refused.
Created by claim_steward · Aug 7, 2026. Every judgment on this page is accompanied by a reasoning trace.